318 filings
Page 2 of 16
POS AM
u3hi0 neggyeiec
20 Jul 18
Prospectus update (post-effective amendment)
4:09pm
POS AM
y2x86d8x4 cyu8n
20 Jul 18
Prospectus update (post-effective amendment)
4:06pm
POS AM
qppppgq3y3 te3s
20 Jul 18
Prospectus update (post-effective amendment)
4:05pm
POS AM
f602y79mu6dsv
20 Jul 18
Prospectus update (post-effective amendment)
4:03pm
25
sgeym1mz
17 Jul 18
Voluntary exchange delisting
2:37pm
8-K
ar8yd5by
9 Jul 18
Anthera Pharmaceuticals Announces SEC Deregistration
4:39pm
8-K
g9vgtlgjz
27 Jun 18
Anthera Pharmaceuticals Announces Withdrawal of its Nasdaq Hearing Request
4:12pm
8-K
pvef wbvhwkiyre5h00y
18 Jun 18
Departure of Directors or Certain Officers
4:30pm
8-K
s9i6zo36tm0j1 ecc
30 May 18
Other Events
5:25pm
8-K
bbfstydhr768co53ulv
23 May 18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:25pm
8-K
pfcxjg2d3pcy od8
16 Apr 18
Cost Associated with Exit or Disposal Activities
12:00am
EFFECT
pnoakprp6tum lp
27 Mar 18
Notice of effectiveness
12:00am
8-K
ggn yv8aczriz
12 Mar 18
Anthera Pharmaceuticals Reports Top Line Data from
12:00am
8-K
pv2rcldk9a2iq kep2z
5 Mar 18
Anthera Pharmaceuticals Provides Business Update and Reports
12:00am
8-K
4pqf7 4ggxiwrbd
25 Jan 18
Anthera Receives Positive Nasdaq Listing Determination
12:00am
D/A
k33hkf 6db9hvr0elfx9
11 Jan 18
$15M in equity / options, sold $15M, 21 investors
12:00am
8-K
77px4e2yy 362x
9 Jan 18
Anthera Pharmaceuticals Announces Second Closing of $15 Million Private Placement Offering
12:00am